216 related articles for article (PubMed ID: 23970381)
21. Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009.
Lehrnbecher T; Groll AH; Cesaro S; Alten J; Attarbaschi A; Barbaric D; Bodmer N; Conter V; Izraeli S; Mann G; Möricke A; Niggli F; Schrappe M; Stary J; Zapotocka E; Zimmermann M; Elitzur S
Leukemia; 2023 Jan; 37(1):72-78. PubMed ID: 36509893
[TBL] [Abstract][Full Text] [Related]
22. Fungal diagnostic testing and therapy: navigating the neutropenic period in children with high-risk leukemia.
Fisher BT
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):361-367. PubMed ID: 34889439
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and Predictors of Invasive Fungal Infections in Children with Persistent Febrile Neutropenia Treated for Acute Leukemia - A Prospective Study.
Kumar J; Singh A; Seth R; Xess I; Jana M; Kabra SK
Indian J Pediatr; 2018 Dec; 85(12):1090-1095. PubMed ID: 29956075
[TBL] [Abstract][Full Text] [Related]
24. Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy: A Multicenter, Prospective, Observational Study in China.
Wang L; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Medicine (Baltimore); 2016 Jan; 95(4):e2560. PubMed ID: 26825897
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea.
Yoo JH; Choi SM; Lee DG; Choi JH; Shin WS; Min WS; Kim CC
J Korean Med Sci; 2005 Feb; 20(1):31-5. PubMed ID: 15716598
[TBL] [Abstract][Full Text] [Related]
26. Voriconazole Antifungal Prophylaxis in Children With Malignancies: A Nationwide Study.
Pana ZD; Kourti M; Vikelouda K; Vlahou A; Katzilakis N; Papageorgiou M; Doganis D; Petrikkos L; Paisiou A; Koliouskas D; Kattamis A; Stiakaki E; Chatzistilianou M; Vasilatou-Kosmidis H; Polychronopoulou S; Grafakos S; Roilides E
J Pediatr Hematol Oncol; 2018 Jan; 40(1):22-26. PubMed ID: 28816795
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia.
Tu S; Zhang K; Wang N; Chu J; Yang L; Xie Z
Sci Rep; 2023 Nov; 13(1):18789. PubMed ID: 37914820
[TBL] [Abstract][Full Text] [Related]
28. Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.
Arikan K; Aytac S; Büyükcam A; Cengiz AB; Cetinkaya FD; Cetin M; Ozsurekci Y; Ceyhan M; Kara A
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e613-e618. PubMed ID: 33560081
[TBL] [Abstract][Full Text] [Related]
29. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M
Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
[TBL] [Abstract][Full Text] [Related]
30. Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
Zhang R; Chen J; Huang H; Ma J; Meng F; Tang Y; Hu J; Zhang X; Ji Y; Ai H; Liang Y; Wu D; Huang X; Han M
Int J Hematol; 2017 Aug; 106(2):221-228. PubMed ID: 28390035
[TBL] [Abstract][Full Text] [Related]
31. Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis.
Kaya Z; Gursel T; Kocak U; Aral YZ; Kalkanci A; Albayrak M
Pediatr Blood Cancer; 2009 Apr; 52(4):470-5. PubMed ID: 19058205
[TBL] [Abstract][Full Text] [Related]
32. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
33. Invasive Fungal Infections in Children with Leukemia: Clinical Features and Prognosis.
Sezgin Evim M; Tüfekçi Ö; Baytan B; Ören H; Çelebi S; Ener B; Üstün Elmas K; Yılmaz Ş; Erdem M; Hacımustafaoğlu MK; Güneş AM
Turk J Haematol; 2022 Jun; 39(2):94-102. PubMed ID: 34792308
[TBL] [Abstract][Full Text] [Related]
34. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
[TBL] [Abstract][Full Text] [Related]
35. [Epidemiology and risk factors for prolonged hospital length of stay in children with leukemia and bacteremia. Cohort study].
Taicz M; Pérez MG; Reijtman V; Mastroianni A; Escarra F; García ME; Varela AN; Guitter M; Romero J; Ghibaudi G; Gómez S; Bologna R
Rev Chilena Infectol; 2018; 35(3):233-238. PubMed ID: 30534901
[TBL] [Abstract][Full Text] [Related]
36. Antifungal Therapy in Pediatric Acute Lymphoblastic Leukemia: A Single-center Experience.
Yigit M; Arman Bilir Ö; Kanik Yüksek S; Kaçar D; Özbek NY; Yarali HN
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e653-e657. PubMed ID: 34486550
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia.
Schrenk KG; Schnetzke U; Stegemann K; von Lilienfeld-Toal M; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1661-8. PubMed ID: 25800622
[TBL] [Abstract][Full Text] [Related]
38. [Breakthrough of invasive fungal disease with posaconazole as primary prophylaxis after induction chemotherapy for acute myeloid leukemia].
Pei RZ; Lu Y; Zhang PS; Liu XH; Chen D; Du XH; Sha KY; Li SY; Cao JJ; Chen LG; Zhuang XX; Tang SH
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):213-217. PubMed ID: 32146748
[No Abstract] [Full Text] [Related]
39. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
Rodríguez-Veiga R; Montesinos P; Boluda B; Lorenzo I; Martínez-Cuadrón D; Salavert M; Pemán J; Calvillo P; Cano I; Acuña E; Villalba A; Piñana JL; Sanz J; Solves P; Senent L; Vicente A; Sempere A; Cervera J; Barragán E; Jarque I; Torres A; Sanz MA; Sanz GF
Ann Hematol; 2019 Sep; 98(9):2081-2088. PubMed ID: 31240471
[TBL] [Abstract][Full Text] [Related]
40. Voriconazole prophylaxis in leukemic patients: A retrospective single-center study.
Bui V; Walker SA; Elligsen M; Vyas A; Kiss A; Palmay L
J Oncol Pharm Pract; 2020 Jun; 26(4):873-881. PubMed ID: 31566111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
